Llwytho...
Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis
Leflunomide is a disease-modifying antirheumatic drug (DMARD) that has been in routine clinical use for the treatment of rheumatoid arthritis (RA) and psoriatic arthritis for a decade. In RA, clinical trials of up to two years’ duration showed that leflunomide monotherapy was equivalent to methotrex...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Open Access Rheumatol |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Dove Medical Press
2010
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5074775/ https://ncbi.nlm.nih.gov/pubmed/27789998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OARRR.S9448 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|